Skip to main content

Dalrada Technology Group, Inc.

corporate_fare Company Profile

Dalrada Technology Group, Inc.

ITEC·OTC·Trade & Services·CIK 0000725394

Dalrada Financial Corporation accelerates positive change by developing transformative products and services across five business divisions: Genefic, Dalrada Climate Technology, Dalrada Precision Manufacturing, Dalrada Technologies, and Dalrada Corporate. The company's global solutions address climate change, healthcare industry gaps, and technology needs. The Genefic division provides advanced healthcare solutions, including products, services, and systems. This division focuses on developing key health products, medications, and comprehensive systems to improve quality of life and longevity globally. Genefic includes two main entities: Genefic Specialty Pharmacy, formerly Genefic Specialty Pharmacy Rx Solutions, is an Alabama-based pharmacy with over 30 years of experience in the retail medical and pharmaceutical industries. It specializes in expert care and disease state management through prescription management, education, nursing, and total health solutions. Genefic Pharmacy holds pharmacy licenses in all 50 States and Washington D.C. Genefic Infusion Rx is a Louisiana-based infusion pharmacy that manages all aspects of fluid and medication infusion via intravenous or subcutaneous application. It supports healthcare systems by enhancing the infusion process through efficient authorization and prescription management.

Dalrada Technology Group, Inc. (OTC:ITEC) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 4 items for ITEC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-02-21, rated 9/10. Across its 4 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for ITEC spans 10-Q, 8-K/A, 8-K.

Recent high-impact activity:

  • Dalrada Reports Worsening Financials, Going Concern, Material Weakness, and Details Highly Dilutive Financing
  • Dalrada Amends Financing Disclosure, Increasing Highly Dilutive Obligation to $25 Million
  • Dalrada Subsidiary Secures $25M Financing with Onerous Terms, Pledging Parent Assets and CEO Personal Guarantee
  • Dalrada CEO Details Strategic Refocus, Reports €720K Water Generator Order Amid Operational Progress Near 52-Week Low

No longer listed

ITEC (Dalrada Technology Group, Inc.) is no longer listed on a major US exchange, so Wiseek no longer shows market data for this symbol. It last appeared on NASDAQ. The filings and coverage below remain available as an archive.

feed ITEC - Latest Insights

ITEC
Feb 20, 2026, 9:31 PM EST
Filing Type: 10-Q
Importance Score:
9
ITEC
Feb 02, 2026, 5:22 PM EST
Filing Type: 8-K/A
Importance Score:
9
ITEC
Jan 27, 2026, 5:02 PM EST
Filing Type: 8-K
Importance Score:
9
ITEC
Jan 20, 2026, 10:48 AM EST
Filing Type: 8-K
Importance Score:
8
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets